Back to Trades
Melincoff Gwen A
DirectorCIK 0001614890
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Melincoff Gwen A, Director, has filed 3 SEC reports (2025–2026), spread across 3 companies, totaling $66.6K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 17 | GANX Gain Therapeutics, Inc. | Melincoff Gwen A | Director | Award | $42.0K |
| Jun 3 | CMMB Chemomab Therapeutics Ltd. | Melincoff Gwen A | Director | Other | $0 |
| Sep 4 | PLX Protalix BioTherapeutics, Inc. | Melincoff Gwen A | Insider | Grant | $24.6K |
3 filings